ALDX
Price
$5.29
Change
-$0.10 (-1.86%)
Updated
Oct 17, 11:50 AM (EDT)
Capitalization
323.65M
27 days until earnings call
Intraday Buy/Sell Signals
ANEB
Price
$2.60
Change
+$0.08 (+3.17%)
Updated
Oct 17, 10:53 AM (EDT)
Capitalization
103.53M
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ALDX vs ANEB

Header iconALDX vs ANEB Comparison
Open Charts ALDX vs ANEBBanner chart's image
Aldeyra Therapeutics
Price$5.29
Change-$0.10 (-1.86%)
Volume$1.2K
Capitalization323.65M
Anebulo Pharmaceuticals
Price$2.60
Change+$0.08 (+3.17%)
Volume$177
Capitalization103.53M
ALDX vs ANEB Comparison Chart in %
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. ANEB commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and ANEB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (ALDX: $5.39 vs. ANEB: $2.52)
Brand notoriety: ALDX and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 81% vs. ANEB: 28%
Market capitalization -- ALDX: $323.65M vs. ANEB: $103.53M
ALDX [@Biotechnology] is valued at $323.65M. ANEB’s [@Biotechnology] market capitalization is $103.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileANEB’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • ANEB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALDX and ANEB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while ANEB’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 6 bearish.
  • ANEB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANEB is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -4.94% price change this week, while ANEB (@Biotechnology) price change was +8.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +17.05%, and the average quarterly price growth was +80.61%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

ANEB is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($324M) has a higher market cap than ANEB($104M). ANEB YTD gains are higher at: 50.000 vs. ALDX (8.016). ANEB has higher annual earnings (EBITDA): -7.27M vs. ALDX (-48.46M). ALDX has more cash in the bank: 81.9M vs. ANEB (13.3M). ALDX (0) and ANEB (0) have equivalent revenues.
ALDXANEBALDX / ANEB
Capitalization324M104M312%
EBITDA-48.46M-7.27M667%
Gain YTD8.01650.00016%
P/E RatioN/AN/A-
Revenue00-
Total Cash81.9M13.3M616%
Total Debt15.6MN/A-
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXANEB
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKOMF43.254.52
+11.67%
Tokio Marine Holdings, Inc.
HLTRF4.02N/A
N/A
HLS Therapeutics Inc.
SKSUF18.29N/A
N/A
Sekisui Chemical Co.
TUFBY6.69N/A
N/A
Thai Union Group Public Company Limited
SRCGF0.06-0.01
-17.20%
HOMELAND NICKEL INC.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.77%
CANF - ALDX
46%
Loosely correlated
+2.27%
CMVLF - ALDX
39%
Loosely correlated
+93.85%
CLLS - ALDX
39%
Loosely correlated
+9.98%
PLRX - ALDX
38%
Loosely correlated
+5.10%
ARVN - ALDX
37%
Loosely correlated
+2.33%
More

ANEB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-7.35%
ABVX - ANEB
52%
Loosely correlated
-2.82%
AVXL - ANEB
31%
Poorly correlated
-0.22%
CLSD - ANEB
29%
Poorly correlated
-9.85%
TECX - ANEB
28%
Poorly correlated
+1.79%
ALDX - ANEB
28%
Poorly correlated
-4.77%
More